Skip to main content
. 2012 Jan 18;5(1):47–51. doi: 10.1159/000336156

Fig. 1.

Fig. 1

Normal magnetic resonance imaging (a, b) and diffusion-weighted magnetic resonance imaging (c) of the brain during an episode of irinotecan-induced dysarthria.